Skip to main content
CriticalFDAfda-F-2534-2017LISTERIA

The Smokehouse of NY Smoked Norwegian Fish packaged as: 4oz & 8oz and whole sides

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
0
Recall Date
June 21, 2017
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2534-2017.

Potential for Listeria monocytogenes contamination

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2534-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact The Smokehouse Of New York, Llc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2534-2017.

The Smokehouse of New York, LLC.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

The Smokehouse Of New York, Llc. Recall FAQ

The Smokehouse Of New York, Llc. is the subject of a seafood safety report: The Smokehouse of NY Smoked Norwegian Fish packaged as: 4oz & 8oz and whole sides. The notice was published on June 21, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.